Reply to Brynedal et al.: Accumulating genetic and functional evidence for a role of CD58 in multiple sclerosis

Por De Jager, Philip L.
Publicado em 2009

Identifying Patient Subtypes in Multiple Sclerosis and Tailoring Immunotherapy: Challenges For the Future

Por De Jager, Philip L.
Publicado em 2009

An inflection point in gene discovery efforts for neurodegenerative diseases: From syndromic diagnoses towards endophenotypes and the epigenome

Por De Jager, Philip L., Bennett, David
Publicado em 2013

Translational Research Epigenomics

Por Replogle, Joseph M., De Jager, Philip L.
Publicado no Transl Res (2014)

An ∼1.2-Mb Bacterial Artificial Chromosome Contig Refines the Genetic and Physical Maps of the Lurcher Locus on Mouse Chromosome 6

Por De Jager, Philip L., Zuo, Jian, Heintz, Nathaniel
Publicado em 1997

Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease

Por Bennett, David A., Yu, Lei, De Jager, Philip L.
Publicado em 2014

The epigenome in Alzheimer’s disease: Current state and approaches for a new path to gene discovery and understanding disease mechanism

Por Klein, Hans-Ulrich, Bennett, David A., De Jager, Philip L.
Publicado no Acta Neuropathol (2016)

Neurodegeneration in Lurcher Mice Occurs via Multiple Cell Death Pathways

Por Doughty, Martin L., De Jager, Philip L., Korsmeyer, Stanley J., Heintz, Nathaniel
Publicado no J Neurosci (2000)

Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles

Por Bennett, David A., De Jager, Philip L., Leurgans, Sue E., Schneider, Julie A.
Publicado em 2009

Genetic variants in Alzheimer disease – molecular and brain network approaches

Por Gaiteri, Chris, Mostafavi, Sara, Honey, Christopher, De Jager, Philip L., Bennett, David A.
Publicado no Nat Rev Neurol (2016)

A scalable online tool for quantitative social network assessment reveals potentially modifiable social environmental risks

Por Dhand, Amar, White, Charles C., Johnson, Catherine, Xia, Zongqi, De Jager, Philip L.
Publicado no Nat Commun (2018)

The Molecular and Neuropathological Consequences of Genetic Risk for Alzheimer's Dementia

Por Tasaki, Shinya, Gaiteri, Chris, Mostafavi, Sara, De Jager, Philip L., Bennett, David A.
Publicado no Front Neurosci (2018)

Complex relation of HLA-DRB1*1501, age at menarche, and age at multiple sclerosis onset

Por Bove, Riley, Chua, Alicia S., Xia, Zongqi, Chibnik, Lori, De Jager, Philip L., Chitnis, Tanuja
Publicado no Neurol Genet (2016)

Bayesian integrative analysis of epigenomic and transcriptomic data identifies Alzheimer's disease candidate genes and networks

Por Klein, Hans-Ulrich, Schäfer, Martin, Bennett, David A., Schwender, Holger, De Jager, Philip L.
Publicado no PLoS Comput Biol (2020)

Allelic variant in CTLA4 alters T cell phosphorylation patterns

Por Maier, Lisa M., Anderson, David E., De Jager, Philip L., Wicker, Linda S., Hafler, David A.
Publicado em 2007

Association of APOE with Tau-Tangle Pathology with and without β-amyloid

Por Farfel, Jose M., Yu, Lei, De Jager, Philip L., Schneider, Julie A., Bennett, David A.
Publicado no Neurobiol Aging (2015)

Common Risk Alleles for Inflammatory Diseases Are Targets of Recent Positive Selection

Por Raj, Towfique, Kuchroo, Manik, Replogle, Joseph M., Raychaudhuri, Soumya, Stranger, Barbara E., De Jager, Philip L.
Publicado em 2013

Epigenomics of Alzheimer’s Disease

Por Bennett, David A., Yu, Lei, Yang, Jingyun, Srivastava, Gyan P., Aubin, Cristin, De Jager, Philip L.
Publicado no Transl Res (2014)

Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort

Por Bove, Riley, Healy, Brian C., Musallam, Alexander, Glanz, Bonnie I., De Jager, Philip L., Chitnis, Tanuja
Publicado no Mult Scler (2015)

A dopamine receptor genetic variant enhances perceptual speed in cognitive healthy subjects

Por Barral, Sandra, Habeck, Christian G., Gazes, Elaine, De Jager, Philip L., Bennett, David A., Stern, Yaakov
Publicado no Alzheimers Dement (N Y) (2017)